- Home
- GRWG vs ADAG Comparison
GRWG vs ADAG Comparison
Compare GRWG & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- ADAG
- Stock Information
- Founded
- GRWG 2008
- ADAG 2011
- Country
- GRWG United States
- ADAG China
- Employees
- GRWG N/A
- ADAG N/A
- Industry
- GRWG RETAIL: Building Materials
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- GRWG Consumer Discretionary
- ADAG Health Care
- Exchange
- GRWG Nasdaq
- ADAG Nasdaq
- Market Cap
- GRWG 98.0M
- ADAG 110.8M
- IPO Year
- GRWG N/A
- ADAG 2021
- Fundamental
- Price
- GRWG $1.60
- ADAG $2.04
- Analyst Decision
- GRWG Strong Buy
- ADAG Strong Buy
- Analyst Count
- GRWG 1
- ADAG 2
- Target Price
- GRWG $2.50
- ADAG $7.00
- AVG Volume (30 Days)
- GRWG 561.0K
- ADAG 111.6K
- Earning Date
- GRWG 11-11-2025
- ADAG 08-12-2025
- Dividend Yield
- GRWG N/A
- ADAG N/A
- EPS Growth
- GRWG N/A
- ADAG N/A
- EPS
- GRWG N/A
- ADAG N/A
- Revenue
- GRWG $164,108,000.00
- ADAG $103,204.00
- Revenue This Year
- GRWG N/A
- ADAG $9,789.15
- Revenue Next Year
- GRWG N/A
- ADAG $29.92
- P/E Ratio
- GRWG N/A
- ADAG N/A
- Revenue Growth
- GRWG N/A
- ADAG N/A
- 52 Week Low
- GRWG $0.82
- ADAG $1.33
- 52 Week High
- GRWG $2.27
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- GRWG 54.64
- ADAG 45.09
- Support Level
- GRWG $1.59
- ADAG $2.24
- Resistance Level
- GRWG $1.74
- ADAG $2.49
- Average True Range (ATR)
- GRWG 0.11
- ADAG 0.22
- MACD
- GRWG -0.02
- ADAG -0.03
- Stochastic Oscillator
- GRWG 39.39
- ADAG 0.44
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.